Joint Formulary & PAD

Avanafil - Erectile dysfunction

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Avanafil
Indication :
Erectile dysfunction
Group Name :
Keywords :
ED, impotence, phosphodiesterase type 5 inhibitors, PDE5 inhibitors, PDE-5
Brand Names Include :
Spedra
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Avanafil is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Erectile dysfunction.

Committee Recommendations (1)

The Surrey Heartlands APC have reviewed the treatments for erectile dysfunction.

Avanafil remains non-formulary.

Sildenafil or tadalafil are the preferred treatment options.

Combination treatments (oral & non oral)
These treatments should not be used in combination with other treatments for erectile dysfunction due to the limited evidence available to support their use.